相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
Gary A. Ulaner et al.
CLINICAL CANCER RESEARCH (2019)
Prospective Study of Serial F-18-FDG PET and F-18-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer
Lanell M. Peterson et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
F-18-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients
Hilde H. Nienhuis et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Clinical Potential of Estrogen and Progesterone Receptor Imaging
Hannah M. Linden et al.
PET CLINICS (2018)
Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer
Andrei Iagaru et al.
PET CLINICS (2018)
18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials
Yingbing Wang et al.
CLINICAL CANCER RESEARCH (2017)
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer
Brenda F. Kurland et al.
CLINICAL CANCER RESEARCH (2017)
Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma
Zheling Chen et al.
PLOS ONE (2017)
[18F] Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy
Malene Grubbe Hildebrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Molecular Imaging of Biomarkers in Breast Cancer
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study
Funmilayo I. Tade et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression
Erin Currin et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype
Brittany Z. Dashevsky et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Positron emission tomography of tumour [18F] fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
Michel van Kruchten et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
Molly P. Hogan et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Measuring Residual Estrogen Receptor Availability during Fulvestrant Therapy in Patients with Metastatic Breast Cancer
Michel van Kruchten et al.
CANCER DISCOVERY (2015)
Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics
Amy E. McCart Reed et al.
BREAST CANCER RESEARCH (2015)
Distant Metastatic Disease Manifestations in Infiltrating Lobular Carcinoma of the Breast
Hongying He et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2014)
A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)
Lanell M. Peterson et al.
MOLECULAR IMAGING AND BIOLOGY (2014)
PET imaging of oestrogen receptors in patients with breast cancer
Michel van Kruchten et al.
LANCET ONCOLOGY (2013)
Frequency and etiology of unexplained bilateral hydronephrosis in patients with breast cancer: results of a longitudinal CT study
Ari J. Kane et al.
CLINICAL IMAGING (2012)
Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer
Hannah M. Linden et al.
CLINICAL CANCER RESEARCH (2011)
Simplified and automatic one-pot synthesis of 16α-[18F] fluoroestradiol without high-performance liquid chromatography purification
K. E. Knott et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2011)
Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by 18F-Fluoroestradiol PET
Brenda F. Kurland et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer
Farrokh Dehdashti et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004
Christie R. Eheman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Invasive Lobular Carcinoma of the Breast: Spectrum of Mammographic, US, and MR Imaging Findings
January K. Lopez et al.
RADIOGRAPHICS (2009)
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: Combined results of 15 International Breast Cancer Study Group clinical trials
Bernhard C. Pestalozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles
F. Bertucci et al.
ONCOGENE (2008)
18F-fluoroestradiol
Lavanya Sundararajan et al.
SEMINARS IN NUCLEAR MEDICINE (2007)
Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast
Brian J. Yoder et al.
BREAST JOURNAL (2007)
Clinical characteristics of different histologic types of breast cancer
CI Li et al.
BRITISH JOURNAL OF CANCER (2005)
Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer
WA Berg et al.
RADIOLOGY (2004)
Trends in incidence rates of invasive lobular and ductal breast carcinoma
CI Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
FDG uptake in breast cancer:: correlation with biological and clinical prognostic parameters
A Buck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography
R Bos et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose:: Use and limitations
N Avril et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Metastatic lobular carcinoma of the breast: Patterns of spread in the chest, abdomen, and pelvis on CT
CB Winston et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2000)
分享论文
